Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 774.55, up by 5.95 points or 0.77 % from its previous closing of Rs. 768.60 on the BSE.

The scrip opened at Rs. 776.50 and has touched a high and low of Rs. 781.10 and Rs. 773.50 respectively. So far 58665 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs. 779.50 and Rs. 734.40 respectively. The current market cap of the company is Rs. 186769.32 crore.

The promoters holding in the company stood at 54.71 % while Institutions and Non-Institutions held 35.62 % and 9.68 % respectively.

As a part of its manufacturing consolidation in the US, Sun Pharmaceutical Industries’ one of wholly owned subsidiaries has entered into an agreement with Nostrum Laboratories Inc. (Nostrum) for the divestment of the Bryan (Ohio) unit in the US.

As a part of the agreement, the Sun Pharma subsidiary has divested this unit as a going concern along with the employees and related products to Nostrum. During the divestment process, Sun Pharma was cognizant that the interests of its employees working in the unit were not compromised.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.